List of insiders holdings for Artiva Biotherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2024-09-03 16:18:05 | 9,853,302 0 |
9,853,302 | Form 13D |
| 2 | GC Corp. GC Cell Corp 10% Owner |
2024-07-29 16:15:58 | 4,567,412 0 |
4,567,412 | Form 13D |
| 3 | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner |
2024-08-01 16:17:22 | 2,353,304 0 |
2,353,304 | Form 13G |
| 4 | Huh Yong-Jun Director |
2024-07-22 20:22:03 | 0 1,810,945 |
1,810,945 | Form 4 |
| 5 | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S 10% Owner |
2024-11-14 16:56:18 | 1,519,971 0 |
1,519,971 | Form 13G |
| 6 | Aslan Fred President and CEO |
2025-03-07 16:35:00 | 416,665 0 |
416,665 | Form 4 |
| 7 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
2024-07-22 20:28:17 | 243,127 0 |
243,127 | Form 4 |
| 8 | Bush Jennifer COO, CLO, Secy, Compliance Off |
2025-02-28 17:15:05 | 159,449 0 |
159,449 | Form 4 |
| 9 | Krishnamohan Neha Chief Financial Officer |
2025-02-28 17:15:08 | 110,000 0 |
110,000 | Form 4 |
| 10 | Horan Christopher Chief Tech Operations Officer |
2025-02-28 17:15:11 | 85,000 0 |
85,000 | Form 4 |
| 11 | Graef Thorsten Chief Medical Officer |
2025-02-28 17:15:13 | 80,000 0 |
80,000 | Form 4 |
| 12 | Raymon Heather SVP, Research and Development |
2025-02-28 17:15:16 | 43,350 0 |
43,350 | Form 4 |
| 13 | MOORE ALISON Director |
2024-10-22 20:18:32 | 27,500 0 |
27,500 | Form 4 |
| 14 | Baker Daniel G. Director |
2025-01-29 16:33:38 | 27,500 0 |
27,500 | Form 4 |
| 15 | Miralles Gines Diego Director |
2024-07-18 20:06:41 | 25,990 0 |
25,990 | Form 3 |
| 16 | HOUGEN ELIZABETH L Director |
2024-07-18 20:04:01 | 17,098 0 |
17,098 | Form 3 |
| 17 | Bessen Laura Director |
2024-07-18 20:02:02 | 17,098 0 |
17,098 | Form 3 |
| 18 | Stoppel Laura Director |
2024-07-18 20:05:15 | 0 0 |
0 | Form 3 |
| 19 | DANIELS BRIAN Director |
2024-07-18 20:03:48 | 0 0 |
0 | Form 3 |